Diabetic Retinopathy

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2015) Diabetic Retinopathy. Medicine, 43 (1). pp. 13-19. doi:10.1016/j.mpmed.2014.10.009

This is the latest version of this item.

Full text not available from this repository.


Diabetic retinopathy is the leading cause of blindness in the working-age population in many countries. Despite the available treatments, some patients present late in the course of the disease when treatment is more difficult. If diabetic retinopathy is detected, tightening of modifiable risk factors (e.g. blood glucose and blood pressure) can slow disease progression. When sight-threatening retinopathy is detected, laser treatment and treatment with vascular endothelial growth factor (VEGF) inhibitors reduces the risk of visual loss.

Item Type: Article
Article Type: Article
Uncontrolled Keywords: diabetic retinopathy; laser therapy; optical coherence tomography; risk factors; screening; vascular endothelial growth factor
Subjects: R Medicine > RA Public aspects of medicine > RA645.A-Z Individual diseases or groups of diseases, A-Z > RA645.D54 Diabetes
R Medicine > RE Ophthalmology
Divisions: Schools and Research Institutes > School of Education and Science
Research Priority Areas: Health, Life Sciences, Sport and Wellbeing
Depositing User: Anne Pengelly
Date Deposited: 01 Jun 2016 12:13
Last Modified: 31 Aug 2023 09:09
URI: https://eprints.glos.ac.uk/id/eprint/3574

Available Versions of this Item

University Staff: Request a correction | Repository Editors: Update this record

University Of Gloucestershire

Bookmark and Share

Find Us On Social Media:

Social Media Icons Facebook Twitter Google+ YouTube Pinterest Linkedin

Other University Web Sites

University of Gloucestershire, The Park, Cheltenham, Gloucestershire, GL50 2RH. Telephone +44 (0)844 8010001.